Cross-institution positioning
Aug 14, 2026Strong institutional reduction. 1 accumulating, 4 exited across 5 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 accumulating, 4 exited across 5 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 2 sales by 2 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +6.3% YoY; Net income -69.6% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 58% through its reported 52-week range; +15.4% over one year.
Source: Stored historical price seriesFiled Aug 14, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Stovall Bryan Lee | SOpen-market or private sale | COMMON STOCK | 2.7K | $150.07 | Direct | Aug 14, 2026 |
| Aug 11, 2026 | Vellines Jeffrey | SOpen-market or private sale | COMMON STOCK | 4.2K | $153.55 | Direct | Aug 11, 2026 |
| Aug 4, 2026 | Davenport Rhonda | AGrant, award, or other acquisition · derivative | Performance Share Units | 512 | $0.00 | Direct | Aug 5, 2026 |
| Aug 4, 2026 | Davenport Rhonda | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 512 | $0.00 | Direct | Aug 5, 2026 |
| Jul 7, 2026 | GRANNUM CLIVE A | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | Purvis Steven R. | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | Treadway Charles L. | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | Schapper Aaron M | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | Jackson Carol R | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | BERCE DANIEL E | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jul 7, 2026 | McGough Ed | AGrant, award, or other acquisition | COMMON STOCK | 937 | $0.00 | Direct | Jul 8, 2026 |
| Jun 30, 2026 | Vellines Jeffrey | JOther transaction | COMMON STOCK | 22 | $91.10 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | Crawford Jason | JOther transaction | COMMON STOCK | 305 | $69.63 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | Mackey Tara D | JOther transaction | COMMON STOCK | 305 | $69.63 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | FERGUSON THOMAS E | JOther transaction | COMMON STOCK | 305 | $69.63 | Direct | Jul 1, 2026 |
| Jun 3, 2026 | Crawford Jason | MExercise or conversion of derivative · derivative | Restricted Stock Units | 1.8K | $0.00 | Direct | Jun 3, 2026 |
| Jun 3, 2026 | Crawford Jason | FTax/price withholding or payment | COMMON STOCK | 717 | $136.87 | Direct | Jun 3, 2026 |
| Jun 3, 2026 | Crawford Jason | MExercise or conversion of derivative | COMMON STOCK | 22 | $0.00 | Direct | Jun 3, 2026 |
| Jun 3, 2026 | Crawford Jason | MExercise or conversion of derivative | COMMON STOCK | 1.8K | $0.00 | Direct | Jun 3, 2026 |
| May 31, 2026 | Stovall Bryan Lee | MExercise or conversion of derivative · derivative | Restricted Stock Units | 9.0K | $0.00 | Direct | Jun 2, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 8, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 3, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Jul 8, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 7, 2026 | 8-K | 5.07, 9.01 | Shareholder vote results; Financial statements / exhibits | — | Filing |
| Jun 25, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| May 28, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 8, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Apr 22, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 9, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Mar 5, 2026 | 8-K/AAmendment | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 5, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Feb 13, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended May 31, 2026 | $448.5M | +6.3% |
| Ended Nov 30, 2025 | $425.7M | +5.5% |
| Ended Aug 31, 2025 | $417.3M | +2.0% |
| Ended May 31, 2025 | $422.0M | +2.1% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Feb 28, 2026 | $1.7B | +4.6% |
| Ended Feb 28, 2025 | $1.6B | +2.6% |
| Ended Feb 29, 2024 | $1.5B | +16.2% |
| Ended Feb 28, 2023 | $1.3B | +151.8% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Jun 30, 2026 observed Aug 14, 2026 filed · 45d Schedule 13G amendment | Exit below reporting threshold | 1.4M -386.3K | 4.60% -7.40 pts | $155.05 | $151.35 | $136.38 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.3M | $136.38 | |||
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment | Exit below reporting threshold | 1.5K -342 | 4.80% -1.20 pts | $155.05 | $150.85 | $136.38 |
Compare AZZ with other securities showing similar institutional activity or recent accumulation across several tracked institutions.